Research

Cost-effectiveness analysis has become one of the most successful economic methods in real-world applications to evaluate medical technologies, and its use continues to expand. However, standard CEA frameworks fail to adequately account for the role of risk aversion in QoL and attendant uncertainty in treatment effects. This can lead to misallocation of resources by health insurers and/or health care systems that rely on it. We develop a relatively straightforward and tractable way for analysts and real-world decision makers to account for these limitations.

This paper uses data from the Health and Retirement Study (HRS) and the Mexican Health and Aging Study (MHAS) to study the cognitive function of Mexican-born older adults residing in the United States (Mexican immigrants).

U.S. adults who were relatively older appeared to have a more optimistic outlook and better mental health during the early stages of the pandemic.

USC-Brooking Schaeffer Initiative researchers lay out strategies to help the newly uninsured transition to Medicaid or the ACA individual market.

A period of complacency and a lack of focus on potential pandemics has meant that documented shortages of personnel, workforce and equipment has limited healthcare delivery.

After testing Los Angeles County residents for antibodies to the new coronavirus, researchers with USC and the department of public health calculated that many more individuals in L.A. County had SARS-CoV-2 antibodies than previously thought.

Between 2004-2012, productivity growth translated into only modest improvement in patient outcomes; most of the growth was realized in the form of lower treatment costs.

The unprecedented impact of COVID‐19 has generated feelings of fear, grief and helplessness for people around the world and for many health professionals these emotions are particularly accentuated.

Schaeffer Initiative researchers quantify the estimated costs of COVID-19 care in the U.S. in a new report.